home / stock / nonof / nonof news


NONOF News and Press, Novo-Nordisk A/S From 01/02/24

Stock Information

Company Name: Novo-Nordisk A/S
Stock Symbol: NONOF
Market: OTC
Website: novonordisk.com

Menu

NONOF NONOF Quote NONOF Short NONOF News NONOF Articles NONOF Message Board
Get NONOF Alerts

News, Short Squeeze, Breakout and More Instantly...

NONOF - Madrigal Pharmaceuticals: A Deeper Look At A Looming NASH Play

2024-01-02 11:12:57 ET Summary Madrigal Pharmaceuticals, Inc. stock has rallied 70% since late October due to a decrease in competitive concerns and a large secondary offering. The company's candidate resmetirom is expected to be the first approved therapy for NASH in March 2024. ...

NONOF - 7 Investments To Avoid In 2024

2024-01-01 07:00:00 ET Summary As is usual at the start of a new year, many Seeking Alpha contributors have shared their lists of where to put your money during 2024. Not losing money with your investments is almost as important as making money. In this article, I will present...

NONOF - Morgan Stanley positive on healthcare services despite election year

2023-12-31 12:00:33 ET More on MCOs UnitedHealth Could Be A Combination Of Dividend Growth And Capital Appreciation In 2024 UnitedHealth: A Dividend Grower To Consider For Your Portfolio Cigna: Sentiment And Fundamentals On Their Side Catalyst Watch: Macau ga...

NONOF - Eli Lilly takes early lead in weight loss drug race, BMO says

2023-12-29 15:06:27 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly: Consider Cutting Before The Southbound Train Leaves (Rating Downgrade) Eli Lilly: Long Path To A Trillion Novo Nordisk: Latest Insights Confirm Exceptionally Bullish Opportunity Key debat...

NONOF - Eli Lilly: Consider Cutting Before The Southbound Train Leaves (Rating Downgrade)

2023-12-23 08:30:00 ET Summary Eli Lilly stock has underperformed the market since my previous caution, raising questions about whether significant optimism has been priced in. At an adjusted forward P/E of more than 50x, LLY investors looking to add at the current levels need to ...

NONOF - Eli Lilly: Long Path To A Trillion

2023-12-21 17:34:44 ET Summary Eli Lilly and Company has had a strong year, and famed investor Ken Langone predicted it will become the first drug company to reach a market cap of $1 trillion. The obesity drug market for GLP-1s is estimated to add up to $15 billion in additional s...

NONOF - Pfizer Is Not Cheap, And The 5.7% Yield Is Not As Safe As You Might Think

2023-12-20 13:46:26 ET Summary Pfizer's stock reached an all-time high in 2021 due to high demand for its COVID-19 vaccine but has since declined by 45% year-to-date. The company has revised its financial guidance for FY24, expecting significantly lower sales and profits. Decl...

NONOF - PepsiCo: A Realistic Path To Over 10% Returns

2023-12-15 18:05:48 ET Summary PepsiCo is one of the most durable and well-diversified consumer staple companies. 2023 has been a challenging year, with elevated interest rates leading people to opt for money markets over dividend kings. The Fed's pivot in 2024 will signify a ...

NONOF - Outset Medical: Another Potential Ozempic Casualty

2023-12-15 17:31:48 ET Summary Today, we take a deeper look at Outset Medical, Inc., a medical technology company aiming to transform the dialysis industry with its Tablo Hemodialysis System. The company's Tablo system offers cost and supply cost reductions and is utilized in over...

NONOF - Celsius: Ride The Weight Loss Drug Hype

2023-12-15 11:34:09 ET Summary Celsius Holdings is a company that specializes in fitness drinks and is tapping into the health-conscious trend. The company's latest quarterly report shows strong financial performance, with a significant increase in revenue and net income. The ...

Previous 10 Next 10